Enloplatin

恩洛铂

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameEnloplatin

Drug Alias Name依络铂enloplatine英络铂enloplatinoenloplatinum +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAlkylating agentsDNA inhibitors

TargetsDNA

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

ATC CodeN/A